KOSPIChemicals014830

Unid

₩52,300▲ 0.19%2026-11-18 close
Market Cap
₩353.9B
Turnover
₩200M
Volume
3.9K
Shares out.
6.8M
PER
5.3×
PBR
0.3×
EPS
₩9,918
Dividend Yield
3.78%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩2,000 per share · Prices as of the 2026-11-18 close

01

Report overview

Unid: Potash Leader Faces Recovery Test After Q3 Operating Loss

Unid, a leading potash chemical producer, posted 14.9% year-on-year revenue growth in Q3 2026 but swung to an operating loss of KRW 2.14 billion, leaving currency, freight costs and the China expansion as the key variables for recovery.

  1. 1

    Annual revenue rose 20.4% to KRW 1.34 trillion in 2025, but operating profit fell 7.9% to KRW 87.9 billion.

  2. 2

    Q3 2026 revenue reached KRW 378 billion (up 14.9% year on year), but the company recorded an operating loss of KRW 2.14 billion and a net loss attributable to controlling shareholders of KRW 4.43 billion.

  3. 3

    The company and brokers pointed to surging freight rates, a currency lagging effect and lower by-product hydrochloric acid prices, while noting that sales volume was not the main problem.

  4. 4

    The company cites the China Yichang plant expansion and normalizing utilization at its Ulsan plant as drivers of recovery.

  5. 5

    The next checkpoints are the Q4 2026 preliminary results, the 2026 annual report and the Q1 2027 quarterly report.

02

Business structure

Unid's core business is potash-based chemicals. A January 2024 securities report cited the company as ranking first globally in potassium hydroxide and potassium carbonate with a 33% share, and reported a 70% share of the Asian potassium hydroxide market in 2022 (90% in Korea, 45% in China).

In the same report, the 2023 nine-month segment mix was 56% domestic chemicals, 36% China chemicals and 8% China energy. By product, potassium hydroxide accounted for about 60%, potassium carbonate about 30% and chlorine-based products about 10%.

Potassium hydroxide is made by electrolyzing potassium chloride, while potassium carbonate is produced by reacting potassium hydroxide with carbon dioxide. Chlorine-based products such as hydrochloric acid and liquid chlorine are by-products, so their selling prices affect overall profitability.

A Butler corporate data compilation shows the Q2 2026 revenue mix as 60% overseas business and 40% chemical business. Domestic production is handled by the Ulsan plant, and the China subsidiary is reported to sell mainly in its domestic market.

Demand for potassium hydroxide is reported to be broadening into alkaline water electrolysis materials, electrolytes and adsorbents. The company is reported to hold a high share of the domestic potassium hydroxide market and has sales bases in China and Southeast Asia through local subsidiaries.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩329B₩18.8B5.7%
2025Q4₩346.3B₩7.6B2.2%
2026Q1₩384.4B₩25.5B6.6%
2026Q2₩399.8B₩24.2B6.1%
2026Q3₩378B-₩2.1B−0.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.4T₩147.9B₩124.3B10.5%13.8%65.2%
2023₩1.1T₩32.1B₩16.3B2.8%1.8%39.4%
2024₩1.1T₩95.4B₩76.2B8.6%7.5%34.8%
2025₩1.3T₩87.9B₩65.3B6.6%6.0%40.8%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Annual revenue went from KRW 1.4 trillion in 2022 to KRW 1.13 trillion in 2023 (down 19.3% year on year), then KRW 1.11 trillion in 2024 (down 1.9%) and KRW 1.34 trillion in 2025 (up 20.4%). Among 2022 to 2025, 2022 was the largest year and 2024 the smallest.

Operating profit fell from KRW 147.9 billion in 2022 to KRW 32.1 billion in 2023 (down 78.3%), rebounded to KRW 95.4 billion in 2024 (up 197.6%), and was KRW 87.9 billion in 2025 (down 7.9%).

The operating margin was 10.5% in 2022, 2.8% in 2023, 8.6% in 2024 and 6.6% in 2025, so margins in 2025 stayed below 2024 even as revenue grew. Net profit attributable to controlling shareholders was KRW 124.3 billion in 2022, KRW 16.3 billion in 2023, KRW 76.2 billion in 2024 and KRW 65.3 billion in 2025.

Net income including non-controlling interests was KRW 126.8 billion in 2022 and KRW 65.3 billion in 2025. Operating cash flow moved from -KRW 128.1 billion in 2022 to KRW 334.7 billion in 2023, then KRW 116.8 billion in 2024 and KRW 89.5 billion in 2025.

In quarterly terms, Q3 2025 revenue was KRW 329 billion with operating profit of KRW 18.8 billion and controlling-shareholder net profit of KRW 16.8 billion. Q4 2025 revenue rose 5.3% quarter on quarter to KRW 346.3 billion, but operating profit fell 59.8% to KRW 7.58 billion.

Q1 2026 revenue was KRW 384.4 billion (up 11.0% quarter on quarter), operating profit KRW 25.5 billion (up 236.4%) and controlling-shareholder net profit KRW 24.9 billion.

Q2 2026 revenue was KRW 399.8 billion (up 4.0%), operating profit KRW 24.2 billion (down 4.9%) and controlling-shareholder net profit KRW 43.1 billion (up 73.1%).

Q3 2026 revenue was KRW 378 billion (down 5.5% quarter on quarter, up 14.9% year on year), with an operating loss of KRW 2.14 billion and a controlling-shareholder net loss of KRW 4.43 billion, both swinging to losses. The four quarters from Q4 2025 to Q3 2026 total KRW 65.8 billion in controlling-shareholder net profit.

05

Industry analysis

A 2024 securities report said demand for potassium hydroxide is broadening into materials for alkaline water electrolysis equipment, electrolytes and adsorbents for direct air capture (L-DAC). The same report estimated 2022 global potassium hydroxide demand at 2 million tons and projected average annual growth of 1.4%.

These are estimates from the time of publication and may differ from current demand. Chlorine prices are a key variable on the price side. In January 2026, Hana Securities expected the China subsidiary to improve on a surge in chlorine prices.

In Q3 2026, however, the China subsidiary saw weak liquid potassium hydroxide and chlorine prices alongside the seasonal off-season. Lower hydrochloric acid prices, a by-product, reduced profit at the domestic subsidiary.

On currency, a negative lagging effect from the lower exchange rate was estimated to add about KRW 6 billion in costs at the domestic subsidiary. On logistics, surging sea freight linked to geopolitical risk was estimated to add about KRW 5 billion in costs at the domestic subsidiary versus the prior quarter.

On competitive position, the company is reported to hold a high share of the domestic and Asian potassium hydroxide markets, and a 33% global share. These figures come from a 2022 base year or a 2024 report, so they may differ from the latest shares.

06

Outlook

At its Q3 2026 results announcement, the company said it would drive a recovery through the China Yichang plant expansion and normalizing utilization at its Ulsan plant. It also said it would improve profitability and raise shareholder value in response to external uncertainty.

The start-up timing and scale of the new capacity are to be confirmed in company disclosures. Preliminary results for the first three quarters of 2026 were reported as revenue of KRW 1.1623 trillion and operating profit of KRW 47.6 billion (announced October 21, 2026; Business Post report).

The Q3 preliminary operating loss of KRW 2.1 billion was reported as falling well short of a market consensus operating profit of KRW 20.8 billion (Pinpoint News report).

Hana Securities' latest report found that sales volume itself was not a major problem, and that currency timing effects and logistics costs hurt profitability. Hana Securities saw room for domestic profitability to improve if the currency lagging effect eases and freight costs decline.

It expects the China subsidiary to improve once the seasonal off-season passes, potassium sales recover and chlorine and liquid potassium hydroxide prices rebound.

A counterview was also raised that if external cost pressures persist or product price recovery is delayed, normalizing volumes alone will not restore profitability.

The next checkpoints are the direction of exchange rates and freight, the trend in potassium chloride prices and whether losses narrow at the domestic and China subsidiaries.

07

Valuation

PER
5.3×
PBR
0.3×
ROE
6.0%
EPS
₩9,918
BPS
₩173,013
Dividend per share
₩2,000

Valuation readings for Unid depend heavily on earnings volatility. Year-end 2025 total equity was KRW 1.08 trillion, of which equity attributable to controlling shareholders was also KRW 1.08 trillion, and total liabilities were KRW 441.9 billion, for a debt ratio of 40.8%.

Compared with the 39.4% debt ratio at end-2023, the capital structure has stayed broadly stable. The current market capitalization is below year-end 2025 total equity, so the market value sits below book value.

On earnings, controlling-shareholder net profit was KRW 65.3 billion in 2025, and the four quarters from Q4 2025 to Q3 2026 total KRW 65.8 billion. Because Q3 2026 posted a controlling-shareholder net loss, quarterly earnings multiples carry limited meaning.

Over several years, controlling-shareholder net profit recovered from KRW 16.3 billion in 2023 to KRW 76.2 billion in 2024 before easing to KRW 65.3 billion in 2025. Valuation therefore depends on the level at which earnings normalize.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Sustained top-line growth and utilization recovery

Q3 2026 revenue reached KRW 378 billion, up 14.9% year on year, and 2025 annual revenue rose 20.4%. According to Hana Securities, domestic utilization normalized to 86% and sales volume rose 1% quarter on quarter. Stable volumes can provide a base for profit recovery.

China expansion and Ulsan utilization

The China Yichang plant expansion and normalizing Ulsan utilization were cited as recovery drivers in the company's October 21, 2026 disclosure. A larger China production base would widen capacity once the new plant runs. Start-up timing and scale still need to be checked against company disclosures.

Possible rebound at the China subsidiary

Hana Securities said the China subsidiary could improve once the seasonal off-season ends, potassium sales recover and chlorine and liquid potassium hydroxide prices rebound. In January 2026 the same firm had expected improvement on a surge in chlorine prices. Profitability there could shift quickly if price trends change.

09

Bear factors

Swing to a Q3 loss

Q3 2026 operating loss was KRW 2.14 billion and the controlling-shareholder net loss was KRW 4.43 billion, both swinging from profit in the prior quarter and the prior-year period. Reports said this fell well short of a market consensus operating profit of KRW 20.8 billion. Revenue growth alone does not guarantee profit recovery when margins fall.

Freight, currency and by-product cost pressure

Hana Securities estimated that surging freight added about KRW 5 billion in costs at the domestic subsidiary versus the prior quarter. A currency lagging effect was estimated to add about KRW 6 billion more. Lower hydrochloric acid prices also reduced by-product income. Several external cost factors combined to push profit into a loss despite better volumes.

Cumulative margin compression

The operating margin fell from 10.5% in 2022 to 2.8% in 2023 and was 6.6% in 2025, while 2025 operating profit declined 7.9%. Q3 2026 then posted an operating loss, further weakening earnings capacity. The margin has not returned to its 2022 level, which can be read as a bearish factor.

10

Risk factors

External variables: currency and freight

The company attributed the Q3 operating loss to surging global sea freight linked to geopolitical risk and sharp currency swings. If geopolitical tensions such as a Middle East conflict persist, freight costs may stay high.

The lagging effect, in which currency moves reach prices and costs at different times, can also swing quarterly results.

China subsidiary: pricing and seasonality

The China subsidiary's profit is exposed to seasonal potassium sales declines and weak chlorine and liquid potassium hydroxide prices, which widen losses. Its Q3 2026 operating loss was KRW 1.7 billion. Whether the expansion translates into sales depends on how quickly prices recover.

Preliminary results may change

The company said Q3 preliminary results may change after the external auditor's review. Q4 2026 results have not yet been disclosed in a periodic report. Differences between preliminary and final figures could change how quarterly results are read.

11

What to watch next

  1. Around January 2027 (expected)

    Q4 2026 preliminary results. Check whether operating profit returns to positive territory and whether currency and freight burdens eased.

  2. Around March 31, 2027 (statutory deadline for the annual report)

    The 2026 annual report's confirmed revenue, operating margin and controlling-shareholder net profit. The key is how the operating margin moved from 6.6% in 2025.

  3. Around May 15, 2027 (statutory deadline for the Q1 quarterly report)

    Q1 2027 results, to see whether the China Yichang expansion is reflected and whether domestic utilization and sales volumes hold.

  4. After December 2026 (timing not yet set)

    Completion and start-up disclosures for the China Yichang expansion, and how the added capacity links to potassium sales volumes.

12

Overall view

Unid holds a top-tier global share in potash-based chemicals. Its 2025 revenue rose to KRW 1.34 trillion, but operating profit fell to KRW 87.9 billion and the operating margin was 6.6%. In Q3 2026, revenue of KRW 378 billion (up 14.9% year on year) was accompanied by an operating loss of KRW 2.14 billion.

External cost factors were cited, including surging freight, a currency lagging effect and lower by-product hydrochloric acid prices, and sales volume was described as not the main problem. The company points to the China Yichang expansion and normalizing Ulsan utilization as recovery drivers.

Bullish factors include top-line growth, utilization recovery and a possible China price rebound. Bearish factors include the Q3 swing to a loss, accumulated cost pressure and the longer-term margin decline.

The next checkpoints are the Q4 2026 preliminary results, the 2026 annual report and the Q1 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. ssl.pstatic.net
  2. butler.works
  3. k5.co.kr
  4. comp.fnguide.com
  5. hanaw.com
  6. ssl.pstatic.net
  7. file.alphasquare.co.kr
  8. hanaw.com
  9. comp.fnguide.com
  10. fntoday.co.kr
  11. epnc.co.kr
  12. specialtimes.co.kr
  13. energy-news.co.kr
  14. pinpointnews.co.kr
  15. msn.com
  16. pinpointnews.co.kr
  17. edaily.co.kr

Report written 2026-11-17 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis